cp wire

CP Wire Articles

Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile in Ph II Trial
  • Ridinilazole treatment resulted in a 59% reduction in recurrence compared to vancomycin
  • C. difficile causes approximately 500,000 infections and 29,000 deaths in the US... read more
Fri, 08/3/18 - 10:03 am
Failed as a Cancer Treatment - Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1
  • Selumetinib granted Orphan Status by the FDA in 2018
  • NF1 gene mutation occurs in approximately one in 3,000 births
  • Array Biopharma claims AZ owes approximately $192 million... read more
Fri, 08/3/18 - 09:23 am
The UK's MHRA Grants Early Access to Anlylam's Patisiran



Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced on 8/3/18 that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has... read more

Fri, 08/3/18 - 09:01 am
BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product

BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology” product. Its flagship BrainScope One product is a multi-modal... read more

Thu, 08/2/18 - 09:59 am
Regenacy Pharmaceuticals and Charcot-Marie-Tooth Association Team Up to Study Ricolinostat
  • There are currently no FDA approved treatments to stop or reverse loss of function in CMT
  • Ricolinostat is currently also being studied by Celgene as a cancer treatment
  • ... read more
Thu, 08/2/18 - 09:13 am

Pages